BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$484M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$450M |
| 3 |
UnitedHealth
UNH
|
+$430M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
Analog Devices
ADI
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$552M |
| 3 |
Netflix
NFLX
|
+$322M |
| 4 |
PepsiCo
PEP
|
+$291M |
| 5 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.39% |
| 2 | Financials | 8.43% |
| 3 | Healthcare | 8.12% |
| 4 | Consumer Discretionary | 8.06% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Inovio Pharmaceuticals
INO
$93M
| $3.64K | ﹤0.01% |
2,231
-1,080
| -33% | -$2.17K |
|
4727
Hagerty
HGTY
$1.32B
| $3.62K | ﹤0.01% |
400
-8,270
| -95% | -$80.2K |
|
|
IGMS
4728
DELISTED
IGM Biosciences
IGMS
| $3.61K | ﹤0.01% |
3,142
-3,492
| -53% | -$6.49K |
|
4729
Quest Resource Holding
QRHC
$30.8M
| $3.6K | ﹤0.01% |
1,385
-3,362
| -71% | -$15.9K |
|
|
BNR
4730
Burning Rock Biotech
BNR
$98M
| $3.6K | ﹤0.01% |
800
| – | – |
|
4731
Lakeland Industries
LAKE
$117M
| $3.6K | ﹤0.01% |
177
| – | – |
|
4732
Pyxis Oncology
PYXS
$191M
| $3.59K | ﹤0.01% |
3,667
-2,243
| -38% | -$2.99K |
|
4733
Schwab US TIPS ETF
SCHP
$16.2B
| $3.55K | ﹤0.01% |
132
-13
| -9% | -$342 |
|
|
PONY
4734
Pony AI Inc
PONY
$3.62B
| $3.53K | ﹤0.01% |
+400
| New | +$5.71K |
|
4735
Acumen Pharmaceuticals
ABOS
$184M
| $3.48K | ﹤0.01% |
3,167
-3,850
| -55% | -$5.5K |
|
4736
Ramaco Resources Class B
METCB
$406M
| $3.43K | ﹤0.01% |
509
-485
| -49% | -$4.08K |
|
|
DM
4737
DELISTED
Desktop Metal, Inc.
DM
| $3.41K | ﹤0.01% |
694
-89
| -11% | -$230 |
|
4738
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $3.38K | ﹤0.01% |
29
-15
| -34% | -$1.7K |
|
4739
LifeVantage
LFVN
$81.9M
| $3.37K | ﹤0.01% |
231
| – | – |
|
|
NOTE
4740
DELISTED
FiscalNote
NOTE
| $3.37K | ﹤0.01% |
347
-488
| -58% | -$7.34K |
|
|
INZY
4741
DELISTED
Inozyme Pharma
INZY
| $3.33K | ﹤0.01% |
3,662
-3,018
| -45% | -$4.18K |
|
|
BLUE
4742
DELISTED
bluebird bio
BLUE
| $3.31K | ﹤0.01% |
679
-3,866
| -85% | -$23.2K |
|
4743
CVR Partners
UAN
$1.26B
| $3.31K | ﹤0.01% |
+44
| New | +$3.44K |
|
4744
Black Diamond Therapeutics
BDTX
$116M
| $3.3K | ﹤0.01% |
2,130
-1,983
| -48% | -$4.16K |
|
4745
Werewolf Therapeutics
HOWL
$18.8M
| $3.27K | ﹤0.01% |
3,365
-3,467
| -51% | -$4.54K |
|
|
KG
4746
Kestrel Group
KG
$60.5M
| $3.19K | ﹤0.01% |
279
-272
| -49% | -$5.13K |
|
4747
Red Robin
RRGB
$183M
| $3.18K | ﹤0.01% |
892
+753
| +542% | +$3.86K |
|
4748
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.38B
| $3.12K | ﹤0.01% |
129
+112
| +659% | +$2.7K |
|
|
MURA
4749
DELISTED
Mural Oncology
MURA
| $3.01K | ﹤0.01% |
2,386
-41
| -2% | -$149 |
|
|
MRDN
4750
Meridian Holdings Inc
MRDN
$178M
| $3K | ﹤0.01% |
127
-206
| -62% | -$5K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2025 Portfolio in Review
As of Q1 2025, BNP Paribas Financial Markets held 5,672 positions worth $170B, down 4.7% from $178B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets's Q1 2025 filing shows 266 new, 2,026 increased, 2,595 reduced and 297 closed positions. Its largest new stake was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.79B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- BNP Paribas Financial Markets's largest Q1 2025 buy was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M.
- BNP Paribas Financial Markets added most to iShares MSCI USA Quality Factor ETF in Q1 2025, an estimated $484M increase.
- BNP Paribas Financial Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.79B.
- BNP Paribas Financial Markets fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q1 2025, selling an estimated $83.2M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $170B portfolio in Q1 2025.
- BNP Paribas Financial Markets opened 266 new positions and closed 297 in Q1 2025.
- BNP Paribas Financial Markets's portfolio value fell 4.7% quarter-over-quarter to $170B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.